{"id":2158,"date":"2020-07-09T14:24:00","date_gmt":"2020-07-09T14:24:00","guid":{"rendered":"https:\/\/negargetni.com\/?p=2158"},"modified":"2024-09-04T08:50:51","modified_gmt":"2024-09-04T08:50:51","slug":"accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen","status":"publish","type":"post","link":"https:\/\/integragen.com\/en\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/","title":{"rendered":"AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN"},"content":{"rendered":"<p><\/p>\n\n\n\n<p><\/p>\n\n\n\n<p>Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at \u20ac2.20 per share, for the entire share capital. This transaction would combine OncoDNA's expertise in precision oncology medicine with IntegraGen's know-how in DNA sequencing and bioinformatics analysis services. The combination of the two companies will make it possible to offer a complete solution combining laboratory tests and software in the field of oncology, for the benefit of patients with advanced cancer.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.businesswire.com\/news\/home\/20200708005949\/fr\/\" target=\"_blank\" rel=\"noreferrer noopener\">To the press release<\/a><\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<p>July 09, 2020<\/p>\n\n\n\n<p>Share :<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity is-style-wide\"\/>\n\n\n\n<ul class=\"wp-block-list\">\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/communiques-de-presse\/integragen-chiffre-daffaires-s1-2020-de-47-me-en-croissance-de-13-et-position-de-tresorerie-de-58-me\/\">IntegraGen - H1 2020 sales of \u20ac4.7m, up +13%, and cash position of \u20ac5.8m<\/a><\/li>\n\n\n\n<li><a href=\"https:\/\/integragen.com\/en\/fr\/actualites\/webinar-analysez-donnees-dexpression-de-rna-seq-de-maniere-autonome-et-interactive-galileo\/\">Webinar: Analyze your RNA-seq expression data autonomously and interactively with Galileo<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at \u20ac2.20 per share, for the entire share capital. This transaction would combine OncoDNA's expertise in precision oncology medicine with IntegraGen's know-how in DNA sequencing and bioinformatics analysis services. The combination of the two companies...<\/p>","protected":false},"author":1,"featured_media":2787,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ca_portfolio_gallery_project_year":"","ca_portfolio_gallery_client":"","ca_portfolio_gallery_skills":"","ca_portfolio_gallery_url":"","ca_portfolio_gallery_images":"","_eb_attr":"","footnotes":""},"categories":[6,1],"tags":[],"class_list":["post-2158","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communiques-de-presse","category-toutes-les-categories"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN<\/title>\n<meta name=\"description\" content=\"Accord en vue d\u2019une offre publique d\u2019achat amicale initi\u00e9e par ONCODNA sur INTEGRAGEN au prix de 2,20\u20ac par action, portant sur la totalit\u00e9 du capital.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/integragen.com\/en\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN\" \/>\n<meta property=\"og:description\" content=\"Accord en vue d\u2019une offre publique d\u2019achat amicale initi\u00e9e par ONCODNA sur INTEGRAGEN au prix de 2,20\u20ac par action, portant sur la totalit\u00e9 du capital.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/integragen.com\/en\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/\" \/>\n<meta property=\"og:site_name\" content=\"IntegraGen\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-09T14:24:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-04T08:50:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"borel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"borel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/\"},\"author\":{\"name\":\"borel\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\"},\"headline\":\"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN\",\"datePublished\":\"2020-07-09T14:24:00+00:00\",\"dateModified\":\"2024-09-04T08:50:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/\"},\"wordCount\":154,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/oncodna-logo-1.png\",\"articleSection\":[\"Communiqu\u00e9s de presse\",\"Toutes les Cat\u00e9gories\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/\",\"name\":\"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/oncodna-logo-1.png\",\"datePublished\":\"2020-07-09T14:24:00+00:00\",\"dateModified\":\"2024-09-04T08:50:51+00:00\",\"description\":\"Accord en vue d\u2019une offre publique d\u2019achat amicale initi\u00e9e par ONCODNA sur INTEGRAGEN au prix de 2,20\u20ac par action, portant sur la totalit\u00e9 du capital.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/oncodna-logo-1.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2020\\\/07\\\/oncodna-logo-1.png\",\"width\":300,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/integragen.com\\\/toutes-les-categories\\\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/integragen.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Communiqu\u00e9s de presse\",\"item\":\"https:\\\/\\\/integragen.com\\\/communiques-de-presse\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#website\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"name\":\"IntegraGen - Clinical Genomic Experts\",\"description\":\"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CRO\",\"publisher\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\"},\"alternateName\":\"IntegraGen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/integragen.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#organization\",\"name\":\"IntegraGen\",\"url\":\"https:\\\/\\\/integragen.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"contentUrl\":\"https:\\\/\\\/integragen.com\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Logo_IntegraGen_OncoDNA.png\",\"width\":2478,\"height\":684,\"caption\":\"IntegraGen\"},\"image\":{\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/integragen\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/integragen.com\\\/#\\\/schema\\\/person\\\/f6280b21a3de1be99b206a61b1b27cd8\",\"name\":\"borel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g\",\"caption\":\"borel\"},\"sameAs\":[\"http:\\\/\\\/nouveausiteintegragen2.local\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN","description":"Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at \u20ac2.20 per share, for the entire share capital.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/integragen.com\/en\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/","og_locale":"en_US","og_type":"article","og_title":"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN","og_description":"Accord en vue d\u2019une offre publique d\u2019achat amicale initi\u00e9e par ONCODNA sur INTEGRAGEN au prix de 2,20\u20ac par action, portant sur la totalit\u00e9 du capital.","og_url":"https:\/\/integragen.com\/en\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/","og_site_name":"IntegraGen","article_published_time":"2020-07-09T14:24:00+00:00","article_modified_time":"2024-09-04T08:50:51+00:00","og_image":[{"width":300,"height":300,"url":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png","type":"image\/png"}],"author":"borel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"borel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#article","isPartOf":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/"},"author":{"name":"borel","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8"},"headline":"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN","datePublished":"2020-07-09T14:24:00+00:00","dateModified":"2024-09-04T08:50:51+00:00","mainEntityOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/"},"wordCount":154,"commentCount":0,"publisher":{"@id":"https:\/\/integragen.com\/#organization"},"image":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#primaryimage"},"thumbnailUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png","articleSection":["Communiqu\u00e9s de presse","Toutes les Cat\u00e9gories"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/","url":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/","name":"AGREEMENT ON A FRIENDLY TAKEOVER BID BY ONCODNA FOR INTEGRAGEN","isPartOf":{"@id":"https:\/\/integragen.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#primaryimage"},"image":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#primaryimage"},"thumbnailUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png","datePublished":"2020-07-09T14:24:00+00:00","dateModified":"2024-09-04T08:50:51+00:00","description":"Agreement on a friendly takeover bid by ONCODNA for INTEGRAGEN at \u20ac2.20 per share, for the entire share capital.","breadcrumb":{"@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#primaryimage","url":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2020\/07\/oncodna-logo-1.png","width":300,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/integragen.com\/toutes-les-categories\/accord-en-vue-dune-offre-publique-dachat-amicale-initiee-par-oncodna-sur-integragen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/integragen.com\/"},{"@type":"ListItem","position":2,"name":"Communiqu\u00e9s de presse","item":"https:\/\/integragen.com\/communiques-de-presse\/"},{"@type":"ListItem","position":3,"name":"ACCORD EN VUE D\u2019UNE OFFRE PUBLIQUE D\u2019ACHAT AMICALE INITI\u00c9E PAR ONCODNA SUR INTEGRAGEN"}]},{"@type":"WebSite","@id":"https:\/\/integragen.com\/#website","url":"https:\/\/integragen.com\/","name":"IntegraGen - Clinical Genomic Experts","description":"NGS Sequencing &amp; Bioinformatics for Pharma, Biotech &amp; CROs","publisher":{"@id":"https:\/\/integragen.com\/#organization"},"alternateName":"IntegraGen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/integragen.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/integragen.com\/#organization","name":"IntegraGen","url":"https:\/\/integragen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/","url":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","contentUrl":"https:\/\/integragen.com\/wp-content\/uploads\/2024\/09\/Logo_IntegraGen_OncoDNA.png","width":2478,"height":684,"caption":"IntegraGen"},"image":{"@id":"https:\/\/integragen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/integragen\/"]},{"@type":"Person","@id":"https:\/\/integragen.com\/#\/schema\/person\/f6280b21a3de1be99b206a61b1b27cd8","name":"borel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7616457667d003266ce8cf944d45183cc7cbef7ec9a7896861e521289a7e8d87?s=96&d=mm&r=g","caption":"borel"},"sameAs":["http:\/\/nouveausiteintegragen2.local"]}]}},"_links":{"self":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/comments?post=2158"}],"version-history":[{"count":1,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2158\/revisions"}],"predecessor-version":[{"id":2160,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/posts\/2158\/revisions\/2160"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media\/2787"}],"wp:attachment":[{"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/media?parent=2158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/categories?post=2158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/integragen.com\/en\/wp-json\/wp\/v2\/tags?post=2158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}